false --12-31 2024 Q1 0001722969 0001722969 2024-01-01 2024-03-31 0001722969 us-gaap:CommonClassAMember 2024-05-10 0001722969 us-gaap:CommonClassBMember 2024-05-10 0001722969 2024-03-31 0001722969 2023-12-31 0001722969 us-gaap:CommonClassAMember 2024-03-31 0001722969 us-gaap:CommonClassAMember 2023-12-31 0001722969 us-gaap:CommonClassBMember 2024-03-31 0001722969 us-gaap:CommonClassBMember 2023-12-31 0001722969 us-gaap:SeriesAPreferredStockMember 2024-03-31 0001722969 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001722969 2023-01-01 2023-03-31 0001722969 NXU:CommonStockClassAMember 2023-12-31 0001722969 NXU:CommonStockClassBMember 2023-12-31 0001722969 NXU:SeriesAConvertiblePreferredStockMember 2023-12-31 0001722969 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001722969 us-gaap:RetainedEarningsMember 2023-12-31 0001722969 NXU:CommonStockClassAMember 2022-12-31 0001722969 NXU:CommonStockClassBMember 2022-12-31 0001722969 NXU:SeriesAConvertiblePreferredStockMember 2022-12-31 0001722969 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001722969 us-gaap:RetainedEarningsMember 2022-12-31 0001722969 2022-12-31 0001722969 NXU:CommonStockClassAMember 2024-01-01 2024-03-31 0001722969 NXU:CommonStockClassBMember 2024-01-01 2024-03-31 0001722969 NXU:SeriesAConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001722969 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001722969 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001722969 NXU:CommonStockClassAMember 2023-01-01 2023-03-31 0001722969 NXU:CommonStockClassBMember 2023-01-01 2023-03-31 0001722969 NXU:SeriesAConvertiblePreferredStockMember 2023-01-01 2023-03-31 0001722969 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001722969 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001722969 NXU:CommonStockClassAMember 2024-03-31 0001722969 NXU:CommonStockClassBMember 2024-03-31 0001722969 NXU:SeriesAConvertiblePreferredStockMember 2024-03-31 0001722969 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001722969 us-gaap:RetainedEarningsMember 2024-03-31 0001722969 NXU:CommonStockClassAMember 2023-03-31 0001722969 NXU:CommonStockClassBMember 2023-03-31 0001722969 NXU:SeriesAConvertiblePreferredStockMember 2023-03-31 0001722969 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001722969 us-gaap:RetainedEarningsMember 2023-03-31 0001722969 2023-03-31 0001722969 2023-12-01 2023-12-26 0001722969 NXU:RetailChargingServicesMember 2024-01-01 2024-03-31 0001722969 NXU:ChargingStationEquipmentMember 2024-03-31 0001722969 NXU:ChargingStationEquipmentMember 2023-12-31 0001722969 us-gaap:LeaseholdImprovementsMember 2024-03-31 0001722969 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001722969 us-gaap:EquipmentMember 2024-03-31 0001722969 us-gaap:EquipmentMember 2023-12-31 0001722969 us-gaap:OfficeEquipmentMember 2024-03-31 0001722969 us-gaap:OfficeEquipmentMember 2023-12-31 0001722969 us-gaap:SoftwareDevelopmentMember 2024-03-31 0001722969 us-gaap:SoftwareDevelopmentMember 2023-12-31 0001722969 us-gaap:VehiclesMember 2024-03-31 0001722969 us-gaap:VehiclesMember 2023-12-31 0001722969 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-03-31 0001722969 us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0001722969 2017-01-01 2017-12-31 0001722969 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2024-03-31 0001722969 NXU:RestrictedStockUnitsClassifiedAsLiabilityMember 2024-01-01 2024-03-31 0001722969 NXU:RestrictedStockUnitsClassifiedAsLiabilityMember 2023-01-01 2023-03-31 0001722969 NXU:RestrictedStockUnitsClassifiedAsEquityMember 2024-01-01 2024-03-31 0001722969 NXU:RestrictedStockUnitsClassifiedAsEquityMember 2023-01-01 2023-03-31 0001722969 us-gaap:StockOptionMember 2024-01-01 2024-03-31 0001722969 us-gaap:StockOptionMember 2023-01-01 2023-03-31 0001722969 NXU:VendorMember 2023-01-01 2023-03-31 0001722969 NXU:ExchangedRSUsMember 2024-02-01 2024-02-23 0001722969 NXU:PublicOfferingMember 2023-02-01 2023-02-21 0001722969 NXU:PublicOfferingMember 2023-02-21 0001722969 NXU:SeriesAWarrantsMember NXU:PublicOfferingMember 2023-02-21 0001722969 NXU:SeriesBWarrantsMember NXU:PublicOfferingMember 2023-02-21 0001722969 NXU:PublicOfferingMember 2023-08-01 2023-08-11 0001722969 NXU:PublicOfferingMember 2023-08-11 0001722969 NXU:GEMGlobalMember 2022-09-01 2022-09-27 0001722969 NXU:GEMGlobalMember us-gaap:CommonClassAMember 2023-09-01 2023-09-27 0001722969 NXU:PublicOfferingMember 2023-10-01 2023-10-23 0001722969 NXU:PublicOfferingMember 2023-10-23 0001722969 us-gaap:CommonClassAMember 2023-12-01 2023-12-27 0001722969 us-gaap:CommonClassAMember 2023-12-27 0001722969 us-gaap:CommonClassAMember 2024-01-29 0001722969 us-gaap:SeriesAPreferredStockMember 2024-01-29 0001722969 NXU:SeriesAConvertiblePreferredStockMember 2024-02-01 2024-02-08 0001722969 NXU:ShareExchangeAgreementMember 2024-02-01 2024-02-08 0001722969 NXU:WarrantLiabilityMember NXU:FirstTrancheMember 2022-11-03 0001722969 NXU:WarrantLiabilityMember NXU:FirstTrancheMember 2022-11-01 2022-11-03 0001722969 us-gaap:CommonClassAMember NXU:PurchaseAgreementMember 2023-01-01 2023-01-05 0001722969 NXU:WarrantLiabilityMember NXU:SecondTrancheMember 2023-01-27 0001722969 NXU:WarrantLiabilityMember NXU:SecondTrancheMember 2023-01-01 2023-01-27 0001722969 NXU:WarrantLiabilityMember NXU:ClassAOrdinarySharesMember 2024-03-31 0001722969 NXU:WarrantLiabilityMember NXU:SeriesBWarrantsMember NXU:August2023Member 2024-01-01 2024-03-31 0001722969 NXU:WarrantLiabilityMember NXU:SeriesBWarrantsMember 2024-01-01 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:FirstTrancheMember 2023-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:PurchaseAgreementMember 2023-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:SecondTrancheMember 2023-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:SeriesBWarrantsMember 2023-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:August2023Member 2023-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:GEMWarrantsMember 2023-12-31 0001722969 NXU:WarrantsOutstandingMember NXU:FirstTrancheMember 2024-01-01 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:PurchaseAgreementMember 2024-01-01 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:SecondTrancheMember 2024-01-01 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:SeriesBWarrantsMember 2024-01-01 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:August2023Member 2024-01-01 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:GEMWarrantsMember 2024-01-01 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:FirstTrancheMember 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:PurchaseAgreementMember 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:SecondTrancheMember 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:SeriesBWarrantsMember 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:August2023Member 2024-03-31 0001722969 NXU:WarrantsOutstandingMember NXU:GEMWarrantsMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:FirstTrancheMember 2024-01-01 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:FirstTrancheMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember 2024-01-01 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SecondTrancheMember 2024-01-01 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SecondTrancheMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesAWarrantsMember 2024-01-01 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesAWarrantsMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember 2024-01-01 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member 2024-01-01 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember 2024-01-01 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember 2024-03-31 0001722969 us-gaap:FairValueInputsLevel3Member 2024-03-31 0001722969 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputMaturityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputMaturityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputMaturityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputMaturityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputMaturityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputMaturityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputExpectedDividendRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputMaturityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputMaturityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputMaturityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputMaturityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputMaturityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputMaturityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheOneMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:PurchaseAgreementMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:TrancheTwoMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:SeriesBWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:August2023Member us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001722969 NXU:CommonStockWarrantsMember NXU:GEMWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

Form 10-Q

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to                 

 

Commission file number 1-41509

 

 

 

Nxu, Inc.

(Exact name of registrant as specified in its charter)

 

 Delaware   92-2819012
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification Number)

 

1828 N. Higley Rd. Ste 116

Mesa, AZ 85205

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (760) 515-1133

Former name, former address and former fiscal year, if changed since last report: N/A

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share NXU NASDAQ

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x    No  ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x    No  ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  ¨ Accelerated filer  ¨
Non-accelerated filer  x Smaller reporting company  x
  Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.           x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  ¨    No  x

 

As of May 10, 2024, there were 11,930,986 and 258,503 shares of the Registrant’s Class A and Class B Common Stock outstanding, respectively, par value $0.0001.

 

 

   
 

 

INDEX

 

      Page
  PART I. FINANCIAL INFORMATION    
       
ITEM 1. Financial Statements   1
       
  Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023 (Unaudited)   1
       
  Condensed Consolidated Statements of Operations for the Three Months Ended
March 31, 2024 and 2023 (Unaudited)
  2
       
  Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the Three Months Ended
March 31, 2024 and 2023 (Unaudited)
  3
       
  Condensed Consolidated Statements of Cash Flows for the Three Months Ended
March 31, 2024 and 2023 (Unaudited)
  4
       
  Notes to Condensed Consolidated Financial Statements (Unaudited)   5
       
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   17
       
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk   22
       
ITEM 4. Controls and Procedures   22
       
  PART II. OTHER INFORMATION    
       
ITEM 1 Legal Proceedings   22
       
ITEM 1A. Risk Factors   22
       
ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds   23
       
ITEM 3 Defaults Upon Senior Securities   23
       
ITEM 4 Mine Safety Disclosures   23
       
ITEM 5 Other Information   23
       
ITEM 6. Exhibits   23
       
  Signatures   25

 

   
 

 

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

NXU, INC. and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands, except share data)
(Unaudited)

           
   March 31, 2024   December 31, 2023 
Assets          
Current Assets:          
Cash  $9,181   $2,846 
Prepaid expenses and other current assets   976    999 
Notes receivable from related party   250    250 
Total current assets   10,407    4,095 
           
Property and equipment, net   4,447    3,865 
Right-of-use assets   2,951    1,507 
Investment in Lynx   3,000    3,000 
Intangible assets, net   30    20 
Other assets   729    772 
Total assets  $21,564   $13,259 
           
Liabilities and Stockholders' Equity (Deficit)          
Current Liabilities:          
Accounts payable and accrued liabilities  $3,498   $3,371 
Variable share settled restricted stock units   1,738    1,334 
Current portion of operating lease liability   1,720    864 
Other current liabilities   -    40 
Total current liabilities   6,956    5,609 
           
Lease liability, net of current portion   1,300    688 
Convertible debt and warrant liability, at fair value   21    65 
Other long-term liabilities   133    233 
Total liabilities   8,410    6,595 
Commitments and contingencies (Note 10)          
           
Stockholders' Equity (Deficit):          
           
Class A Common Stock, par value $0.0001; 4,000,000,000 shares authorized; 11,930,986 issued and outstanding as of March 31, 2024; 2,563,288 issued and outstanding as of December 31, 2023   1     
Class B Common Stock, par value $0.0001; 1,000,000,000 authorized; 252,503 issued and outstanding at March 31, 2024; 243,503 issued and outstanding at December 31, 2023        
Series A Convertible Preferred Stock, par value $0.0001; 5,000 shares authorized; 0 issued and outstanding at March 31, 2024; 1,000 issued and outstanding at December 31, 2023        
Additional paid-in capital   279,332    266,302 
Accumulated deficit   (266,179)   (259,638)
Total stockholders' equity   13,154    6,664 
Total liabilities and stockholders' equity  $21,564   $13,259 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

 - 1 - 
 

 

NXU, INC. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Dollars in thousands, except share and per share data)
(Unaudited)

           
   Three Months Ended March 31, 
   2024   2023 
         
Revenue  $4   $ 
           
Cost of revenue   3     
Depreciation   18     
Total cost of revenue   21     
Gross loss   (17)    
           
Operating expenses:          
Research and development   395    3,962 
General and administrative   6,151    9,488 
Advertising   22    34 
           
Total operating expenses   6,568    13,484 
           
Operating loss   (6,585)   (13,484)
           
Other income (expense):          
Interest expense       (1)
Warrant expense       (983)
Gain on convertible debt and warrant liability   44    2,281 
Other income       17 
           
Total other income, net   44    1,314 
           
Net loss  $(6,541)  $(12,170)
           
Loss per share, basic and diluted  $(0.91)  $(97.48)
           
Weighted average number of common shares outstanding used in computing loss per share:   7,166,858    124,844 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

 - 2 - 
 

 

NXU, INC. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(Amounts in thousands, except share data)
(Unaudited)

                                              
   Common Stock                     
   Class A   Class B   Series A Convertible
Preferred Stock
   Additional   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Paid-in Capital   (Deficit)   Total 
Balance at December 31, 2023   2,563,288   $    243,503   $    1,000   $   $266,302   $(259,638)  $6,664 
                                              
Class A common stock issued for cash under ATM   8,153,574    1                    10,711        10,712 
Class B common stock issued           9,000                         
Conversion of Series A Convertible Preferred Stock   1,000,000                (1,000)                
Stock-based compensation                           2,319        2,319 
Common stock issued under stock compensation plans   214,124                                 
Net loss                               (6,541)   (6,541)
Balance at March 31, 2024   11,930,986   $1    252,503   $       $   $279,332   $(266,179)  $13,154 

 

 

   Common Stock                     
   Class A   Class B   Series A Convertible
Preferred Stock
   Additional   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Paid-in Capital   (Deficit)   Total 
Balance at December 31, 2022   65,092   $    207,503   $       $   $210,412   $(219,460)  $(9,048)
                                              
Class A common stock issued for cash   55,314                        4,921        4,921 
Class B common stock issued           9,000                         
Stock-based compensation                           5,824        5,824 
Shares issued for services   573                        72        72 
Exercise of warrants   36,114                        3,300        3,300 
Exercise of stock options   520                        546        546 
Conversion of long term debt to equity   61,430                        14,482        14,482 
Net loss                               (12,170)   (12,170)
Balance at March 31, 2023   219,043   $    216,503   $       $   $239,557   $(231,630)  $7,927 

 

 See accompanying notes to condensed consolidated financial statements (unaudited).

 

 - 3 - 
 

 

NXU, INC. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands)
(Unaudited)

           
   Three Months Ended March 31, 
   2024   2023 
Cash flows from operating activities:          
Net loss  $(6,541)  $(12,170)
Adjustments to reconcile net loss to net cash provided by operating activities:          
Depreciation and amortization   270    142 
Employee stock-based compensation   2,656    5,824 
Non-employee stock-based compensation       72 
Non-cash warrant expense       984 
Net change in operating lease assets and liabilities   24    (6)
Gain on fair value of convertible debt and warrant liability   (44)   (2,281)
Changes in assets and liabilities:          
Prepaid expenses and other current assets   23    (185)
Inventory       (580)
Other assets   43     
Accounts payable and accrued liabilities   182    (1,065)
Other current liabilities       64 
Other long-term liabilities   (100)   (169)
Net cash used in operating activities   (3,487)   (9,370)
           
Cash flows from investing activities:          
Purchases of property and equipment   (839)   (94)
Capitalized patent costs   (11)    
Net cash used in investing activities   (850)   (94)
           
Cash flows from financing activities:          
Proceeds from public offering, net of equity offering costs       12,020 
Proceeds from ATM, net of offering costs   10,712     
Proceeds from the issuance of convertible debt       9,000 
Payments on convertible debt       (1,864)
Payments on financing liability   (40)   (40)
Proceeds from the exercise of stock options       546 
Net cash provided by financing activities   10,672    19,662 
Net decrease in cash   6,335    10,198 
Cash, beginning of period   2,846    2,701 
Cash, end of period  $9,181   $12,899 
           
Supplemental disclosure of cash flow information:          
Cash paid for interest  $   $1 
           
Debt converted to equity  $   $14,481 
Operating lease right-of-use asset obtained in exchange for operating lease liability  $1,861   $ 
Capital expenditures included in accounts payable and other accrued liabilities  $149   $ 
Stock-based compensation expense capitalized to property and equipment  $67   $ 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

 - 4 - 
 

 

NXU, INC. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

1.Organization and Basis of Presentation

 

Reorganization, Merger and Incorporation of Nxu, Inc.

 

On May 12, 2023, Atlis Motor Vehicles Inc. (“Atlis”) completed its previously announced reorganization merger pursuant to the Agreement and Plan of Merger, dated as of April 16, 2023 (the “Reorganization Agreement”), by and among Atlis, Nxu, Inc., a Delaware Corporation (the “Company” or “Nxu”), and Atlis Merger Sub, Inc., a Delaware corporation and, as of immediately prior to the consummation of such merger, a wholly-owned subsidiary of Nxu (“Merger Sub”). The Reorganization Agreement provided for the merger of Atlis and Merger Sub, with Atlis surviving the merger as a wholly-owned subsidiary of Nxu (the “Reorganization Merger”). The Reorganization Agreement was approved and adopted by Atlis’s stockholders at Atlis’s Special Meeting of Stockholders, which was held on May 9, 2023. After the Reorganization Merger, Atlis was reclassified from a corporation to a limited liability company and renamed Nxu Technologies, LLC.  Nxu Technologies, LLC is a wholly owned operating company and the sole subsidiary of Nxu.  References to “Nxu” or the “Company” shall collectively mean Nxu, Inc. and its wholly owned subsidiary, Nxu Technologies, LLC.

 

The directors and executive officers of Nxu immediately following the completion of the Reorganization Merger were the same individuals who were directors and executive officers, respectively, of Atlis as of immediately prior to the Reorganization Merger.

 

Upon completion of the Reorganization Merger, Nxu Class A Common Stock was deemed to be registered under Section 12(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 12g-3(a) promulgated thereunder and for purposes of Rule 12g-3(a), Nxu is the successor issuer to Atlis.

 

Transactions that occurred in connection with the Reorganization Merger are considered transactions between entities under common control, and thus the financial statements for periods prior to the Reorganization Merger have been adjusted to combine the previously separate entities for presentation purpose. See more information regarding shares of common stock authorized, issued and outstanding in connection with the Reorganization Merger in Note 11 – Stock-based Compensation and Common Stock.

 

Organization

 

Nxu is a US-based technology company building megawatt (“MW”) charging stations and developing innovative battery cells and battery packs for use in advanced energy storage systems, and mobility products. The Company believes that widespread adoption of EVs by the commercial and industrial markets requires high performing battery and pack solutions that can effectively compete with legacy diesel-based products. Nxu designs, engineers, and plans to build proprietary 1 megawatt plus charging stations, lithium-ion (“Li-ion”) battery cells and packs, energy storage solutions and a suite of software and services designed to allow an easy transition from diesel to electric for our target segment.  

 

Basis of Consolidation

 

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and the rules of the Securities and Exchange Commission, which require us to make estimates based on assumptions about current, and for some estimates, future economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our estimates contemplate current and expected future conditions, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, our financial position and cash flows. The results for any of the interim periods are not necessarily indicative of the results to be expected for the full year or any other period. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation with respect to interim financial statements, have been included.

 

Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to those rules and regulations. The December 31, 2023 balance sheet was derived from audited financial statements. This Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 ("2023 10-K").

 

 - 5 - 
 

 

References to amounts in the consolidated financial statement sections are in thousands, except share and per share data, unless otherwise specified.

 

Reverse Stock Split

 

On December 26, 2023, the Company effected a 1-for-150 reverse stock split of the shares of common stock of the Company. All historical share and per share amounts reflected throughout the financial statements have been retroactively adjusted to give effect to the reverse stock split. See Note 11 – Stock-based Compensation and Common Stock for further discussion.

 

Correction of Immaterial Misclassification

 

Management identified an immaterial error in classification related to research and development costs previously reported as general and administrative expense in the March 31, 2023 unaudited condensed consolidated financial statements. The correction resulted in an increase to research and development costs of $0.8 million for the three months ended March 31, 2023, respectively, with a corresponding decrease to general and administrative expense. The reclassification of costs allows for a more accurate presentation of research and development costs and had no impact on total operating expenses, net loss, total assets, total liabilities or shareholders’ equity (deficit).

 

Management identified an immaterial error in its previously reported stock-based compensation expense in the March 31, 2023 unaudited condensed consolidated financial statements. Correction of the error resulted in an increase to stock-based compensation expense of $0.1 million as of March 31, 2023. The restatement had no effect on stockholders’ deficit as of December 31, 2023 and had no other effect to the Company's consolidated financial statements.

 

Presentation of Stock-based Compensation Expense

 

The Company had previously presented stock-based compensation as a separate line item on its condensed consolidated Statements of Operations due to the significance of that expense relative to other operating expenses. As of the three months ended March 31, 2024, management began reporting stock-based compensation expense in the same line or lines as cash compensation paid to the same employees or nonemployees, which for the current period resulted in Research and Development or General and Administrative expense based on the role of the employee. Stock-based compensation was reclassified in prior periods using the same basis of allocation and presentation, which resulted in an increase in Research and Development and General and Administrative expense of approximately $0.2 million and $5.6 million, respectively, for the three months ended March 31, 2023.

 

Going Concern

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.  

 

During the three-month period ended March 31, 2024, the Company incurred a net loss of $6.5 million and had net cash used in operating activities of $3.5 million. As of March 31, 2024, the Company had $9.2 million in cash and an accumulated deficit of $266.2 million.

 

The Company cannot provide any assurance that unforeseen circumstances that could occur at any time within the next twelve months or thereafter will not increase the need for the Company to raise additional capital on an immediate basis. Additionally, unforeseen circumstances could occur at any time within the next twelve months or thereafter that could increase the need for the Company to raise additional capital on an immediate basis. The Company cannot provide any assurance that access to capital will be readily available when needed. 

 

These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year after the date these financial statements are issued. Company management is addressing this risk by pursuing all available options for funding, including accessing the public markets through secondary offerings. The Company plans to continue considering all avenues available to it in order to obtain the necessary capital to be able to continue as a going concern and to execute on our business objectives including but not limited to, debt financing, private placements, public offerings and equity lines of credit, and exploring other options, including other strategic alternatives for its business. The Company’s success is dependent upon achieving its strategic and financial objectives, including continuing to acquire capital through public markets as it works diligently to achieve future operational revenue goals. The Company cannot provide any assurance that access to capital will be readily available when needed or that it will be successful in implementing any additional strategic alternative, which may be subject to the satisfaction of conditions beyond the Company’s control.

 

 - 6 - 
 

 

2.Recent Accounting Pronouncements and Summary of Significant Accounting Policies

 

Recent Accounting Pronouncements

 

The Company has reviewed all recently issued accounting pronouncements and concluded that they were either not applicable or not expected to have a material impact on its unaudited condensed consolidated financial statements.

 

Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Due to uncertainties, actual results could differ from the estimates and assumptions used in preparation of the unaudited condensed consolidated financial statements.

 

 - 7 - 
 

 

Stock-based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation-Stock Compensation (“ASC 718”). The Company classifies stock-based awards granted in exchange for services as either equity awards or liability awards. The classification of an award as either an equity award or a liability award is generally based upon cash settlement options. Equity awards are measured based on the fair value of the award at the grant date. Liability awards are granted at a fixed dollar amount settled in a variable number of shares and are measured at fair value at the grant date and remeasured at the end of each reporting period until fully vested. As such, the fair value of awards classified as liabilities at each reporting date approximates the fixed dollar amount at inception.

 

The Company generally recognizes stock-based compensation on a straight-line basis over the award’s requisite service period, which is generally the vesting period of the award, less actual forfeitures. No compensation expense is recognized for awards for which participants do not render the requisite services. For equity and liability awards earned based on performance or upon occurrence of a contingent event, when and if the awards will be earned is estimated. If an award is not considered probable of being earned, no amount of stock-based compensation is recognized. If the award is deemed probable of being earned, related compensation expense is recorded over the estimated service period. To the extent the estimate of awards considered probable of being earned changes, the amount of stock-based compensation recognized will also change.

 

The Company accounts for modification of stock-based compensation awards in accordance with ASC 718-20-35. Upon modification, the Company records any incremental fair value of the modified award as stock-based compensation on the date of modification for vested awards or over the remaining vesting period for unvested awards. The incremental compensation is the excess of the fair value of the modified award on the date of modification over the fair value of the original award immediately before the modification. In addition, the Company records any remaining unrecognized compensation cost for the original cost for the original award on the modification date over the remaining vesting period for unvested awards.

 

See Note 11 – Stock-based Compensation and Common Stock for additional information.

 

3.Revenue

 

In 2023, the Company began recognizing revenue from the delivery of electricity to customer electric vehicles using its NxuOne™ charging station. During the three months ended March 31, 2024, the Company recognized $4.2 thousand of revenue related to retail charging services.

 

During the three months ended March 31, 2024, the Company recognized no revenue from the delivery of battery systems and components.

 

4.Property and Equipment

 

Property and equipment consist of the following (in thousands):

         
   March 31, 2024   December 31, 2023 
         
Charging station equipment  $1,200   $649 
Leasehold improvements   151    151 
Tools and plant equipment   2,715    2,715 
Office equipment   318    318 
Software   1,060    860 
Vehicles   70    70 
Total property and equipment excluding construction in progress   5,514    4,763 
Less: accumulated depreciation and amortization   (1,168)   (898)
Property and equipment excluding construction in progress, net   4,346    3,865 
Charging station equipment and charging site construction in progress   101     
Property and equipment, net  $4,447   $3,865 

 

 - 8 - 
 

 

Depreciation and amortization expense was $0.27 million for the three months ended March 31, 2024, of which $0.25 million was recorded to general and administrative expense, and $0.02 million was expensed to cost of revenue. Depreciation and amortization expense was $0.14 million for the three months ended March 31, 2023, all of which was recorded to general and administrative expense.

 

5.Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets consist of the following (in thousands):

         
   March 31, 2024   December 31, 2023 
         
Tax credit receivable  $466   $372 
Prepaid insurance   300    302 
Prepaid rent   130    98 
Deferred offering costs       102 
Other prepaid expenses   80    125 
Total prepaid expenses and other current assets  $976   $999 

 

6.Other Assets

 

As of March 31, 2024 and December 31, 2023, the entire balance of other assets consisted of security deposits.

 

7.Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consist of the following (in thousands):

         
   March 31, 2024   December 31, 2023 
         
Accounts payable  $2,044   $2,501 
Accrued compensation and benefits   726    153 
Other accrued liabilities   728    717 
Total accounts payable and accrued liabilities  $3,498   $3,371 

 

8.Income Taxes

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company recorded a full valuation allowance due to the uncertainty of future realization of federal and state net operating loss carryforwards.

 

As of March 31, 2024, total net operating loss carryforwards totaled approximately $59.1 million. The Company’s net operating loss carryforwards consist of approximately $16.6 million related to years prior to 2022, which will carryforward through 2037, and approximately $19.9 million and $17.8 million for fiscal years 2022 and 2023, respectively, which will carry forward indefinitely. The Company’s net operating loss carryforward of $4.8 million for the first three months of fiscal year 2024 will also carry forward indefinitely.

 

In December 2017, the U.S. Tax Cuts and Jobs Act of 2017 (“Tax Act”) was enacted into law which significantly revised the Internal Revenue Code of 1986, as amended. The enacted federal income tax law, among other things, contains significant changes to corporate taxation, including a flat corporate tax rate of 21%, limitation of the tax deduction for interest expense to 30% of adjusted taxable income, limitation of the deduction for newly generated net operating losses to 80% of current year taxable income and elimination of net operating loss (“NOL”) carrybacks, future taxation of certain classes of offshore earnings regardless of whether they are repatriated, immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits beginning in 2018.

 

The Company generated an income tax benefit of $1.6 million for the three months ended March 31, 2024, resulting in a cumulative income tax benefit of $62.1 million. The Company has increased its valuation allowance for this deferred tax asset accordingly as the Company’s ability to generate sufficient taxable income to utilize its net operating loss carry forwards is uncertain. The Company’s deferred tax balances primarily consist of its operating loss carryforwards and stock-based compensation.

 

The Company recognizes interest and penalties related to uncertain tax positions in general and administrative expense. At March 31, 2024 and 2023, the Company did not have any unrecognized uncertain tax positions or any associated interest and penalties. 

 

 - 9 - 
 

 

9.Net Loss per Share

 

Net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period, excluding shares of Class B common stock as these shares do not participate in the earnings of the Company. For the three months ended March 31, 2024 and 2023, the Company’s basic and diluted net loss per share were the same because the Company generated a net loss for each period and potentially dilutive securities are excluded from diluted net loss per share as a result of their anti-dilutive impact.

 

The following table presents the calculation of basic and diluted net loss per share during the three months ended March 31, 2024 and 2023 (dollars in thousands, except per share data):

         
   Three Months Ended
March 31,
 
   2024   2023 
         
Numerator:          
Net loss  $(6,541)  $(12,170)
           
Denominator:          
Weighted-average shares of Class A common stock outstanding   7,166,858    124,844 
           
Net loss per share, basic and diluted  $(0.91)  $(97.48)

 

10.Commitments and Contingencies

 

 Registration Rights

 

The holders of the Convertible Notes have registration rights that require the Company to register the sale of their debt securities held by them pursuant to a registration rights agreement, as amended, that was signed in conjunction with the convertible notes. 

 

Contract Losses

 

In December 2021, the Company entered into an agreement (the “Agreement”) with QAD, Inc. (“QAD”), a cloud-based enterprise resource software provider. Under the Agreement, QAD would facilitate implementation services and access to the cloud-based software platform for a non-cancellable, 5-year term. Subsequent to executing the Agreement, the Company determined that the software did not fit the Company’s needs and the Company and QAD (collectively, the “Parties”) were unable to successfully implement the software platform. The Parties attempted to mutually terminate the Agreement but were unsuccessful, and in May 2023, the dispute moved to arbitration to determine whether the Company owed QAD a payment for cancellation of the contract. On October 27, 2023, the Parties agreed to a settlement whereby the Company has agreed to pay a termination fee of $0.70 million to QAD over a 21-month period, upon which the Company will be released from the contract. The Company accrued the portion of the fee due within the next twelve months of $0.4 million in accounts payable and accrued liabilities, and the remaining portion within other long-term liabilities in the Company’s unaudited condensed consolidated balance sheets as of March 31, 2024.  

 

The Company is not currently subject to any other material legal proceedings, nor, to the Company’s knowledge, are any material legal proceedings threatened against the Company. From time to time, the Company may be a party to certain legal or regulatory proceedings in the ordinary course of business. While the outcome of any such future legal or regulatory proceedings cannot be predicted with certainty, management does not expect that any such future proceedings will have a material effect on the Company’s financial condition or results of operations.

 

 - 10 - 
 

 

11.Stock-based Compensation and Common Stock

 

Stock-based Compensation

 

 A summary of stock-based compensation expense recognized during the three months ended March 31, 2024 and 2023 is as follows (in thousands):

         
   Three Months Ended March 31, 
   2024   2023 
         
Restricted stock units (classified as liabilities)  $12   $ 
Restricted stock units (classified as equity)   445     
Stock options   2,266    5,824 
Total stock-based compensation   2,723    5,824 
Stock-based compensation capitalized to property and equipment   (67)    
Stock-based compensation, net of capitalized amount  $2,656   $5,824 

 

As of March 31, 2024, the total unrecognized compensation related to outstanding stock option awards and restricted stock units was $8.9 million, which the Company expects to recognize over a weighted-average period of approximately 1.0 years. Total unrecognized stock-based compensation will be adjusted for actual forfeitures.

 

During the three months ending March 31, 2023, the Company issued 573 shares of its Class A common stock to a vendor for services rendered and recognized $0.1 million of expense related to this issuance.

 

On October 31, 2023, the Company’s Board of Directors approved an amendment to certain existing Executive grant agreements to delay the vesting of service-based liability-classified Executive RSU awards that would have vested between October and December 2023 to vest on January 31, 2024. The Board of Directors subsequently approved additional amendments in January and March 2024 to further delay the vesting of the same RSUs, including vests between January 2024 and May 2024, until June 30, 2024.

 

On March 8, 2024, the Company’s Board of Directors approved an amendment to certain existing Independent Director grant agreements to delay the vesting of service-based liability-classified Director RSU awards that would have vested on March 31, 2024 to vest on June 30, 2024 (collectively with the amendments to Executive grants agreements, the “Amendments”).

 

As of the dates of the Amendments, the Company determined there was no incremental value of the awards in connection with the Amendments. Additionally, as all Executives and Directors affected by the Amendments were still providing service as of March 31, 2024, the Company determined it was probable they would meet the service requirements and their awards would vest within the initial vesting period of the awards. Therefore, the Company recognized stock-based compensation expense at the fair value of the awards through the initial vesting dates. The amended awards will remain classified in liabilities in the consolidated balance sheets of the Company until they are settled in a variable number of shares.

 

On February 23, 2024 (the “Exchange Date”), the Compensation Committee of the Board of Directors authorized a mandatory Exchange Program (the “RSU Exchange Program”) to provide for the cancellation and exchange of approximately $0.4 million of stock-based compensation related to unvested RSUs (“Exchanged RSUs”), previously recorded as liabilities within the unaudited condensed consolidated balance sheets, for an option to purchase shares of Class A common stock of the Company (“Exchange Option”). The Company accounts for the effects of the RSU Exchange Program as a modification of liability-classified awards in accordance with ASC 718.

 

Pursuant to the RSU Exchange Program, the Company granted 1,117,457 Exchange Options to employees, which will vest in equal amounts on March 31, 2024 and June 30, 2024. The Exchange Options have a fair value of $0.7 million, which is equal to the fair value of the Exchanged RSUs at the Exchange Date, and as such no additional compensation cost was recorded as a result of the modification on the Exchange Date. Concurrently with the grant of the Exchange Options, the Company granted 553,236 additional stock options with a fair value of $0.3 million to employees, which will vest in equal amounts on June 30, 2024 and September 30, 2024. Both the Exchange Options and the additional options are classified as equity awards.

 

2023 Omnibus Incentive Plan

 

On May 12, 2023, the Company adopted the 2023 Omnibus Incentive Plan (the”Plan”). The purposes of the Plan are to a) encourage the growth of the Company through short and long-term incentives that are consistent with the Company’s objectives; (b) give participants an incentive for excellence in individual performance; (c) promote teamwork among participants; and (d) give the Company a significant advantage in attracting and retaining key employees, directors and consultants. To accomplish such purposes, the Plan provides that the Company may grant (i) options, (ii) stock appreciation rights, (iii) restricted shares, (iv) restricted stock units, (v) performance-based awards (including performance-based restricted shares and restricted stock units), (vi) other share-based awards, (vii) other cash-based awards or (viii) any combination of the foregoing. The Plan was originally adopted in connection with the consummation of the Company’s Reorganization Merger as contemplated by that certain agreement and plan of merger, dated as of April 14, 2023, by and among the Company, Atlis , and such other parties to the agreement.

 

 - 11 - 
 

 

With respect to awards granted under the Plan and in accordance with the Plan, the Company’s Board of Directors (or the “Administrator”) is authorized to deliver an aggregate of 350 million shares of common stock to be reserved and available for issuance under the Plan (the “Initial Share Limit”), which includes (i) 250 million shares of common stock available for new issuances under the Plan and (ii) 100 million shares of common stock relating to a portion of outstanding stock options and restricted stock units assumed by the Company in connection with the Reorganization Merger; provided, that the total number of shares of common stock that will be reserved, and that may be issued, under the Plan will automatically increase on the first trading day of each calendar year, beginning with calendar year 2024, by a number of common shares equal to five percent (5%) of the total number of outstanding shares on the last day of the prior calendar year. Notwithstanding the foregoing, the Administrator may act prior to January 1 of a given year to provide that there will be no such increase in the share reserve for that year or that the increase in the share reserve for such year will be a lesser number of common shares than provided herein.

 

Common Stock

 

Organizational Structure

 

As described in Note 1 - Organization and Basis of Presentation, on May 12, 2023, Atlis completed its Reorganization Merger to Nxu. At the effective time of the Reorganization Merger, all of the issued and outstanding shares of Atlis’s Class A common stock, par value $0.0001 per share (“Atlis Class A Common Stock”) were converted automatically on a one-for-one basis into shares of Nxu’s Class A common stock, par value $0.0001 per share (“Nxu Class A Common Stock”) and all of the issued and outstanding shares of Atlis’s Class D common stock, par value $0.0001 per share (“Atlis Class D Common Stock” and, together with Atlis Class A Common Stock, “Atlis Common Stock”) were converted automatically on a one-for-one basis into shares of Nxu’s Class B common stock, par value $0.0001 per share (“Nxu Class B Common Stock” and, together with Nxu Class A Common Stock, “Nxu Common Stock”), and, as a result, the current stockholders of Atlis automatically became stockholders of Nxu, holding the same number and percentage of shares of Nxu Common Stock as they held of Atlis Common Stock as of immediately prior to the Reorganization Merger.

 

Issuance and conversion of shares of common stock pursuant to the Reorganization Merger are considered transactions between entities under common control. As a result, the unaudited condensed consolidated financial statements for periods prior to these transactions have been adjusted to combine the previously separate entities for presentation purposes.

 

Except as otherwise required by applicable law, and the voting rights described below, shares of Class A common stock and Class B common stock have the same rights, privileges and powers, rank equally, share ratably and be identical in all respects and as to all matters. The voting, dividend, liquidation and other rights, powers and preferences of the holders of Class A common stock and Class B common stock are subject to and qualified by the rights, powers and preferences of the holders of the preferred stock of any series as may be designated by the Board of Directors of the Corporation (the “Board”) upon any issuance of the preferred stock of any series.

 

In addition, at the effective time of the Reorganization Merger, (i) each outstanding option to purchase shares of Atlis Class A Common Stock (“Atlis Option”), whether vested or unvested, automatically converted into an option to purchase shares of Nxu Class A Common Stock (a “Nxu Option”) and (ii) each outstanding Atlis restricted share unit (an “Atlis Restricted Share”), whether vested or unvested, automatically converted into a restricted stock unit of Nxu (a “Nxu RSU”). Each Nxu Option is subject to terms and conditions consistent with the Employee Stock Option Plan and the applicable Atlis Option award agreement as in effect immediately prior to the effective time. Each Nxu RSU is subject to terms and conditions consistent with the applicable Atlis Restricted Share award agreement as in effect immediately prior to the effective time.

 

At the effective time of the Reorganization Merger, (i) each outstanding Senior Secured Original Issue 10% Discount Convertible Promissory Note (an “Atlis Note”) convertible into shares of Atlis Class A Common Stock automatically converted into a Senior Secured Original Issue 10% Discount Convertible Promissory Note convertible into shares of Nxu Class A Common Stock (a “Nxu Note”) and (ii) each outstanding warrant to purchase shares of Atlis Class A Common Stock (an “Atlis Warrant”) automatically converted into a warrant to purchase shares of Nxu Class A Common Stock (a “Nxu Warrant”). Each Nxu Note is subject to terms and conditions consistent with the applicable Atlis Note as in effect immediately prior to the effective time. Each Nxu Warrant is subject to terms and conditions consistent with the applicable Atlis Warrant as in effect immediately prior to the effective time.

 

In 2022, the Company began issuing Class B shares of common stock. These shares are not traded openly nor available for sale to the public. Class B shares are offered only to the (1) Chief Executive Officer and (2) President of the Company. At all meetings of stockholders and on all matters submitted to a vote of stockholders of the Corporation generally, each holder of Class A common stock, as such, shall have the right to one (1) vote per share of Class A common stock held of record by such holder and each holder of Class B common stock, as such, shall have the right to ten (10) votes per share of Class B common stock held of record by such holder. The shares of Class B common stock are not entitled to receive any dividends or any distribution upon voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. Class B shares are not convertible, are deemed to have no economic value, and upon a holder’s cessation of service to the Company, such holder shall, on the one-year anniversary of such cessation, surrender to the Company for no consideration all shares of Class B shares owned by such holder.

 

Common Stock Offerings

 

On February 21, 2023, the Company completed a public offering of 0.1 million units at a public offering price of $234.00 per unit (the “February 2023 Offering”). Each unit consists of one share of Class A common stock, Series A warrants to purchase 0.65 shares of Class A common stock (the “Series A Warrants”), and Series B warrants to purchase 0.75 shares of Class A common stock (the “Series B Warrants”). See Note 13 - Convertible Notes and Warrant Liability for more information regarding the Series A and Series B warrants. Proceeds from the offering, net of offering costs, were approximately $12.0 million.

 

 - 12 - 
 

 

On August 11, 2023, the Company completed a public offering of 0.1 million units at an offering price of $45.00 per unit (the “August 2023 Offering”). Each unit consists of one share of Class A common stock (or a pre-funded warrant in lieu thereof) and one common warrant, with each warrant exercisable for two shares of Class A common stock at an exercise price of $45.00 per share (the “August 2023 Warrants). See Note 13 - Convertible Notes and Warrant Liability for more information regarding the August 2023 Warrants. Proceeds from the offering, net of offering costs, were approximately $4.5 million.

 

On September 27, 2022, a stock purchase agreement between the Company and GEM Global Yield LLC SCS and GEM Yield Bahamas Limited, respectively (together, “GEM Global”) became effective whereby GEM Global committed to purchase up to $300.0 million in shares of the Company’s Class A common stock for up to three years (the “GEM Stock Purchase Facility”). In connection with the GEM Stock Purchase Facility, GEM Global would earn a commitment fee proportionate to number of shares sold in the first year, or a $6.0 million commitment fee on September 27, 2023 if no shares were sold. As of September 27, 2023, the Company had not sold any shares under the GEM Stock Purchase Facility and, as such, registered 0.3 million Class A common shares, 0.2 million of which were immediately issuable to GEM Global for payment of the commitment fee. Additionally, in connection with the share registration, approximately 2 thousand warrants were issuable to GEM Global. On October 2, 2023, the 0.2 million shares of Class A common stock and 2 thousand common stock warrants were issued to GEM Global.

 

On October 23, 2023, the Company completed a public offering of 0.6 million shares of its Class A common stock at an offering price of $5.25 per share (the “October 2023 Offering”). Proceeds from the offering, net of offering costs, were approximately $2.6 million.

 

In November 2023, the Company launched its ATM pursuant to its shelf registration on Form S-3 for sale from time to time of up to $75.0 million of Class A common stock. As of March 31, 2024, the Company has issued and sold approximately 9.1 million shares of its Class A common stock, resulting in $14.0 million of proceeds, net of commissions and offering costs.

 

Series A Convertible Preferred Stock

 

Share Exchange Agreement with Lynx Motor Corporation

 

On December 27, 2023,  the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with Lynx, pursuant to which Lynx sold to the Company, and the Company purchased from Lynx, a number of newly issued shares of Lynx representing 15% of the issued and outstanding equity interests in Lynx in exchange for 1,000 newly issued shares of series A convertible preferred stock, par value $0.0001 per share, of the Company (the “Series A Convertible Preferred Stock” or “Series A Convertible Preferred Shares”). Each Series A Convertible Preferred Share is convertible into 1,000 shares of Class A common stock, par value $0.0001 per share, of the Company for a conversion price of $3.00 per share. The Share Exchange Agreement contains customary representations and warranties by the Company. As a part of the transaction, the Company designated one person to serve on the board of directors of Lynx. The Company’s investment in Lynx is presented within investment in Lynx at the fair market value of the Series A Convertible Preferred Stock on the transaction date, with the corresponding issuance of Series A Convertible Preferred Stock presented within stockholders’ equity in the unaudited condensed consolidated balance sheets.

  

On January 29, 2024, the Company registered 1.0 million shares of Class A common stock, par value $0.0001, pursuant to the terms of its Share Exchange Agreement with Lynx, under which Nxu sold to Lynx 1,000 shares of Series A convertible preferred stock, par value $0.0001, which are convertible into shares of Class A common stock. The Company did not sell any shares of its Class A common stock and received no proceeds from the offering. On February 8, 2024, Lynx converted all the Series A Convertible Preferred Stock into 1.0 million shares of Class A common stock.

 

Concurrently with the Share Exchange Agreement, Lynx issued a non-interest bearing promissory note in the principal amount of $0.3 million to the Company in exchange for $0.3 million in immediately available funds from the Company. The note is due and payable by June 2024, and is presented in notes receivable from related party in the unaudited condensed consolidated balance sheets.

 

The total number of shares of all classes of capital stock which the Company has authority to issue is 5.0 billion shares, consisting of (1) 5.0 billion authorized shares of common stock, including (a) 4.0 billion authorized shares of Class A Common Stock, (b) 1.0 billion authorized shares of Class B common stock and (2) 10.0 million authorized shares of preferred stock, par value $0.0001 per share. 

 

12.Convertible Notes and Warrant Liability

 

Convertible Notes

 

On November 3, 2022, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (collectively, the “Investors”), pursuant to which the Company agreed to issue to the Investors Senior Secured Original Issue 10% Discount Convertible Promissory Notes (“Convertible Notes” or “Notes”) and common stock warrants to purchase a number of shares of the Company’s Class A common stock equal to 30% of the face value of the Notes divided by the volume weighted average price (“VWAP”), in three tranches.

 

 - 13 - 
 

 

The Convertible Notes are convertible solely into Class A common stock of the Company at a conversion price of (a) $2,250 per share (“Fixed Conversion Price”) or (b) 92.5% of the average of the three lowest daily VWAP of the common stock during the ten-trading day period (“Variable Conversion Price”), whichever is lower. The Fixed Conversion Price includes a one-time reset at the six-month anniversary of the Original Issuance Date (the “Reset Date”) to the lower of the conversion price (with the Variable Conversion Price determined as if the conversion notice was delivered on the Reset Date) and 130% of the daily VWAP of the common stock for the trading day immediately prior to the Reset Date.

 

All Convertible Notes and related common stock warrants, by written agreement, provide for a beneficial ownership limitation cap of 4.99% shares of the total issued and outstanding common stock of the Company, at any given time. Upon an event of default, the Convertible Notes earn interest at a rate of 10% per annum.

 

First Tranche

 

On November 3, 2022, the Company issued the first tranche of the Convertible Notes in the aggregate principal amount of $10.0 million and common stock warrants to purchase up to an aggregate of 1,543 shares of Class A common stock (the “First Tranche”) to the Investors pursuant to the Purchase Agreement for net proceeds of $9.0 million. These Convertible Notes have a maturity date of 24 months from the issuance date. Subsequently, upon reaching the Reset Date, the exercise price of the remaining balance was changed to $96.05 per share. These Convertible Notes are secured by a first priority security interest in all of the assets of the Company.

 

On January 5, 2023, the Company entered into an amendment to the Purchase Agreement (the “Purchase Agreement Amendment”), pursuant to which the Company and each Investor agreed, among other things, to amend the terms and conditions of the second tranche of funding and terminate the third tranche of funding contemplated under the Purchase Agreement. In connection with the Purchase Agreement Amendment, the Company also issued a warrant to the Investors to purchase up to an aggregate of 3,587 shares of the Company’s Class A common stock (the “Purchase Agreement Amendment Tranche”).

 

Second Tranche

 

On January 27, 2023, the Investors exercised their rights to purchase the allowable amounts under the Purchase Agreement Amendment and the Company issued the second tranche of the Convertible Notes in the aggregate principal amount of $10.0 million and common stock warrants to purchase up to an aggregate of 6,281 shares of Class A common stock (the “Second Tranche”) to the Investors pursuant to the Purchase Agreement for net proceeds of $9.0 million. These Convertible Notes have a maturity date of 24 months from the issuance date. Subsequently, upon reaching the Reset Date, the exercise price of the remaining balance was changed to $112.32 per share.

 

The Company elected the fair value option to account for the Convertible Notes, as further discussed in Note 13 – Fair Value. As such, the Company recorded the Convertible Notes at fair value and subsequently remeasures them at fair value at each reporting date. Changes in fair value are recognized as a component of other income (expense), net in the unaudited condensed consolidated statements of operations. Activity related to the Company’s Convertible Notes during the three month period ended March 31, 2024 were as follows (in thousands): 

     
  

Three Months Ended

March 31, 2024

 
     
Balance at December 31, 2023  $10 
Convertible Notes issued during the period    
Conversions    
Payments    
Change in fair value measurement    
Convertible Notes liability at March 31, 2024  $10 

 

 - 14 - 
 

 

Warrant Liability 

 

As discussed in previous sections of this Form 10-Q, the Company has issued warrants in connection with various capital raises. The following tables summarizes the Company’s warrants outstanding as of March 31, 2024 and December 31, 2023:

 

                               
    First
Tranche
   Purchase
Agreement
Amendment
   Second
Tranche
   Series B   August 2023   GEM
Warrants
 
December 31, 2023    1,543    3,587    6,281    33,605    62,223    2,270 
Issued                         
Exercised                         
March 31, 2024    1,543    3,587    6,281    33,605    62,223    2,270 

 

                
Common Stock
Warrants
  Issue Date  Reset Date  Exercise
Price at
Issuance
   Reset
Exercise
Price
 
First Tranche  11/3/2022  5/3/2023  $2,250   $88.65 
Purchase Agreement Amendment  1/5/2023  6/5/2023  $2,250   $87.38 
Second Tranche  1/27/2023  7/30/2023  $2,250   $103.68 
Series A  2/21/2023  No Reset  $    N/A 
Series B  2/21/2023  No Reset  $234(1)   N/A 
August 2023  8/11/2023  No Reset  $45(2)   N/A 
GEM Warrants  10/2/2023  No Reset  $26.54    N/A 

 

(1)Excludes 4,800 of remaining warrants authorized to exercise for no consideration, as discussed below.
(2)Excludes pre-funded warrants, as discussed below.

 

In connection with the issuance of the Convertible Notes, the Investors received a number of common stock warrants equal to 30% of the face value of the Convertible Notes divided by the VWAP prior to the applicable closing date. The common stock warrants entitle the holder to purchase one share of the Company’s Class A common stock at the exercise price of a) $2,250 per share (“Exercise Price”) or (b) 92.5% of the average of the three lowest daily VWAP of the common stock during the ten-trading day period (“Variable Exercise Price”), whichever is lower. The Exercise Price included a one-time reset at the six-month anniversary of the initial exercise date (the “Reset Date”) to the lower of the initial Exercise Price and 120% of the daily VWAP on the trading day prior to the Reset Date. The common stock warrants issued in First Tranche, Purchase Agreement Amendment Tranche, and Second Tranche have a five-year exercise period from their respective issuance date. Subsequently to their issuance, upon reaching the Reset Date, the Exercise Price of these warrants was changed to $88.65, $87.38, and $103.68 per share for the First Tranche, Purchase Agreement Amendment Tranche, and Second Tranche, respectively.

 

As discussed in Note 11 – Stock-based Compensation and Common Stock, in connection with the February 2023 Offering, the purchasing shareholders received Series A and Series B Warrants with each Class A common share issued. All Series A warrants were exercised following issuance for no consideration. The Series B Warrants were exercisable upon completion of the Reorganization Merger and will expire five years from the merger date.

 

As discussed in Note 11 – Stock-based Compensation and Common Stock, in connection with the August 2023 Offering, the purchasing shareholders received August 2023 Warrants with each Class A common share issued. The Company also issued pre-funded warrants (the “Pre-Funded Warrants”) which were immediately exercisable for one share of Class A common stock at an Exercise Price of $0.0001 and do not expire until exercised. The August 2023 Warrants were immediately exercisable and expire three years from the date of issuance. All of these Pre-Funded Warrants were exercised in 2023.

 

In connection with the August 2023 Offering, the Company amended existing Series B warrant agreements to authorize certain Investors to purchase 12,865 shares of the Company’s Class A common stock for no consideration. As of March 31, 2024, 8,065 of these Series B warrants were exercised. Series B warrants are accounted for as liabilities and the fair market value of the warrants is remeasured at the end of every reporting period. As such, the change in the valuation of the liabilities related to the Series B warrant agreements are reflected in the Company’s unaudited condensed consolidated balance sheets as of March 31, 2024.

 

 - 15 - 
 

 

The First Tranche, Purchase Agreement Amendment tranche, Second Tranche, Series A, Series B, and August 2023 Warrants (together, the “Common Stock Warrants”) contain a feature that precludes them from being considered indexed to the Company’s own stock and therefore are accounted for as liabilities in the Company’s unaudited condensed consolidated balance sheets. The Company records the Common Stock Warrants at fair value and subsequently remeasures unexercised warrants to fair value at the reporting date, and further discussed in Note 13 – Fair Value. Activity related to the Company’s warrants during the three month period ended March 31, 2024 were as follows (in thousands): 

     
   March 31,
2024
 
     
Balance at December 31, 2023  $55 
Warrants issued during the period    
Warrants exercised during the period    
Change in fair value measurement   (44)
Warrant liability at March 31, 2024  $11 

 

13.Fair Value

 

The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at March 31, 2024 and December 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value (in thousands).

            
Description:  Level  March 31, 2024   December 31, 2023 
Convertible Notes  3  $10   $10 
Warrant liability  3   11    55 
Convertible Notes and warrant liability, at fair value     $21   $65 

 

Convertible Notes 

  

The following table provides the fair value and contractual principal balance outstanding of the Convertible Notes accounted for under the fair value option as of March 31, 2024 and December 31, 2023: 

         
   March 31, 2023    December 31, 2023 
Convertible Notes fair value  $10   $10 
Convertible Notes, contractual principal outstanding   10    10 
Fair value less unpaid principal balance  $   $ 

 

As of March 31, 2024 and December 31, 2023, the Second Tranche of Convertible Notes was fully converted, and a nominal amount of the First Tranche was outstanding.

 

Warrant Liability 

  

The following tables provide quantitative information regarding Level 3 fair value measurements for Common Stock Warrants as of March 31, 2024 and December 31, 2023. 

                         
   March 31, 2024 
   First
Tranche
   Purchase
Agreement
Amendment
   Second
Tranche
   Series B
Warrants
   August
2023
   GEM
Warrants
 
                         
Risk-free interest rate   4.21%   4.21%   4.21%   4.32%   4.21%   4.21%
Time to expiration (in years)   3.59    3.76    3.76    3.89    2.36    1.41 
Expected volatility   85%   85%   85%   85%   85%   85%
Dividend yield                        
Stock price  $0.68   $0.68   $0.68   $0.68   $0.68   $0.68 
Exercise price  $88.65   $87.38   $103.68   $234.00   $45.00   $26.54 

 

                        
   December 31, 2023 
   First
Tranche
   Purchase
Agreement
Amendment
   Second
Tranche
   Series B
Warrants
   August
2023
   GEM
Warrants
 
                         
Risk-free interest rate   3.84%   3.84%   3.84%   3.91%   3.84%   3.84%
Time to expiration (in years)   3.84    4.01    4.01    4.14    2.61    1.66 
Expected volatility   90%   90%   90%   125%   85%   90%
Dividend yield                        
Stock price  $2.30   $2.30   $2.30   $2.30   $2.30   $2.30 
Exercise price  $88.65   $87.38   $103.68   $234.00   $45.00   $26.54 

 

 - 16 - 
 

 

15.Subsequent Events

 

Nasdaq Bid Price Deficiency Letter

 

On April 2, 2024, the Company received a notice from Nasdaq stating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq (the “Bid Price Requirement”). 

 

Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations

 

Cautionary Note Concerning Forward-Looking Statements

 

The Securities and Exchange Commission (“SEC”) encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This Quarterly Report on Form 10-Q for the three months ended March 31, 2024 (this “Form 10-Q”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates,” “could,” “may,” “estimates,” “expects,” “projects,” “intends,” “plans,” “believes,” “will” and words or phrases of similar substance used in connection with any discussion of future operations, financial performance, plans, events, trends or circumstances can be used to identify some, but not all, forward-looking statements. In particular, statements regarding our ability to continue as a going concern; our belief that additional funding will be required in order to continue operations; our plans to seek additional funding in the form of potential equity and/or debt financing arrangements or similar transactions, strategic alternatives for our business; expectations and opportunities, industry trends, new product expectations and capabilities, and our outlook regarding our performance and growth are forward-looking statements. This Form 10-Q also contains statements regarding plans, goals and objectives. There is no assurance that we will be able to carry out our plans or achieve our goals and objectives or that we will be able to do so successfully on a profitable basis. These forward-looking statements are just predictions and involve significant risks and uncertainties, many of which are beyond our control, and actual results may differ materially from these statements. Factors that could cause actual outcomes or results to differ materially from those reflected in forward-looking statements include, but are not limited to, those discussed in this Item 2 (including in the section entitled “Overview” below), Part II, Item 1A of this Form 10-Q, and under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on April 1, 2024 (the “2023 Form 10-K”). Investors are urged not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date on which they were made. Except as may be required by law, we do not undertake any obligation, and expressly disclaim any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements contained herein are qualified in their entirety by the foregoing cautionary statements.

 

The following discussion of our results of operations and financial condition should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in Part I, Item 1 of this Form 10-Q and our audited consolidated financial statements and the notes thereto in the 2023 Form 10-K.

 

Our investor relations website is located at https://investors.nxuenergy.com. At or through the Investor Relations section of our website, we make available free of charge our Annual Reports on Form 10-K, other reports and all amendments to these reports as soon as practicable after the reports are electronically filed with or furnished to the SEC. Additionally, the Company uses its website, nxuenergy.com and social media channels including Instagram, YouTube, Facebook, LinkedIn, and X (formerly known as Twitter) (@Nxu) to disclose information about the Company and its products to customers, investors, and the public. It is important to note that this information is not incorporated by reference in any reports or documents filed with the SEC, and website URLs are intended to be inactive textual references only. The information posted on these channels may be considered material, so investors should monitor them in addition to press releases, SEC filings, and public conference calls and webcasts. By enrolling your email address to any of our newsletters, you may receive automatic alerts and other information about Nxu.

 

Unless the context otherwise requires, the terms “we”, “us”, “our”, “Nxu” and “Company” refer to Nxu, Inc. and its consolidated subsidiaries.

 

 - 17 - 
 

 

Company Overview

  

Nxu, Inc. is a US-based technology company building energy and infrastructure solutions for consumers and businesses to enable faster transition to electrification across all market segments. We design, engineer, and build megawatt charging stations, innovative battery cells and battery packs for use in advanced energy storage systems and mobility products. We believe that widespread adoption of electric vehicles (“EVs”) across all market segments, especially by the commercial and industrial markets requires high performing battery and pack solutions that can effectively compete with legacy diesel-based products in terms of capability, performance and charge time. We design, engineer, and build NxuOne™ charging station and plan to build proprietary Li-ion battery cells, energy storage solutions and a suite of software and services designed to allow an easy transition from diesel to electric for our target segment.

 

On May 12, 2023, Atlis Motor Vehicles Inc. (“Atlis”), our predecessor company, completed its previously announced reorganization merger pursuant to the Agreement and Plan of Merger, dated as of April 16, 2023 (the “Reorganization Agreement”), by and among Atlis, Nxu, and Atlis Merger Sub, Inc., a Delaware corporation and, as of immediately prior to the consummation of such merger, a wholly-owned subsidiary of Nxu (“Merger Sub”). The Reorganization Agreement provided for the merger of Atlis and Merger Sub, with Atlis surviving the merger as a wholly-owned subsidiary of Nxu (the “Reorganization Merger”). The Reorganization Agreement was approved and adopted by Atlis’s stockholders at Atlis’s Special Meeting of Stockholders, which was held on May 9, 2023.

 

Nxu is an early-stage company and as such, has incurred losses from operations and have had negative cash flows from operating activities since our inception.

 

In light of our liquidity position and anticipated future funding requirements, we continue to pursue additional funding in the form of potential equity and/or debt financing arrangements or similar transactions and explore other strategic alternatives and potential options for our business, including, but not limited to, cost and restructuring initiatives. Even if we are successful in raising additional funding and/or implementing a strategic alternative, we will continue to require additional funding. The Company cannot provide any assurance that access to capital will be readily available when needed or that it will be successful in implementing any additional strategic alternative, which may be subject to the satisfaction of conditions beyond the Company’s control.

 

Company and Industry Outlook

 

We are focused on building products to capture the commercial and industrial markets which represent a portion of the electric vehicle opportunity that we believe is not fully serviced by existing EV solutions. Individuals and companies that make up these segments require vehicles and equipment that are comparable in performance to their existing diesel-powered vehicles and equipment. However, limited battery capacity, range anxiety, and long charge times continue to be primary challenges to electrification. We are developing products aimed at addressing these challenges. Our planned products include our proprietary mega-watt charging infrastructure and energy storage solutions, and, in the long-term, a return to our proprietary battery cells, a modular and scalable electric powered platform, and an electric pickup truck.

 

Our strategy is to focus on execution, both in the near-term and in the long-term. Following a shift in focus in the latter half of 2023, we have continued developing and producing our NxuOne™ megawatt charging station in our Mesa, Arizona facility. As of March 31, 2024, we have successfully launched our first charging station and produced multiple production units ready for deployment. Production costs, including costs of materials and labor, have reduced with each unit produced, as we focus on scale and efficiency.

 

However, in the first quarter of 2024, we incurred losses from the operation of our first NxuOne™ charging station, primarily as a result of discounts offered to customers in the first half of the quarter to continue to generate customer interest. We expect to continue to incur losses on the delivery of electricity to customer electric vehicles until we obtain sufficient capital to efficiently scale our production capabilities and develop charging site real estate, increase production volume, and deploy additional NxuOne™ charging systems for public use.

 

Our operations have been financed primarily through net proceeds from the sale of securities. During the three months ended March 31, 2024, we raised approximately $10.7 million net, after expenses, through our “At-The-Market” equity offering (“ATM”). The Company intends to continue obtaining additional capital through the public markets and other means as described throughout this Form 10-Q. There can be no assurance that we will obtain a sufficient level of capital through these channels in the time frames needed to sustain or grow the business or on terms agreeable to us.

 

Segment Information

 

We evaluated segment reporting in accordance with Accounting Standards Codification 280 – Segment Reporting and concluded that Nxu is comprised of one operating segment. We report segment information based on the operating results regularly reviewed by the chief operating decision maker to make decisions about resource allocation and the performance of the business.

 

 - 18 - 
 

 

Revenue and Profitability

 

Focus on Megawatt Charging

 

During the three months ended March 31, 2024, we generated revenue from the operation of our NxuOne™ megawatt charging station delivering electricity to consumer and commercial customer electric vehicles in Mesa, Arizona. We expect to continue to generate revenue from charging customer vehicles. Sales of electricity to consumer and commercial customers for electric vehicle charging generated losses during the quarter, primarily as a result of discounted prices offered to customers near the beginning of the year to generate customer interest and encourage high charging station utilization, and due to the cost of depreciation. In the future, our goal is to continue to drive customer interest while focusing on increasing opportunities for profitability through utilization of our NxuOne™ charging station network, competitive pricing, and deployment of additional NxuOne™ charging stations.

 

For the year ended December 31, 2023, we generated revenue totaling approximately $0.5 million through the sale of battery systems and components. As we continue to concentrate the Company’s resources on the production of megawatt charging systems, we have not continued to generate revenue from the production and sale of battery systems and components.

 

Production Investment and Cost Management

 

We achieved success in our strategic focus to reduce costs of operations and scale the production of our NxuOne™ megawatt charging system in the three months ended March 31, 2024. During the quarter, we doubled our production of units from the prior quarter and reduced costs of materials and labor through product development, process efficiency and team organization. We believe continued execution through a sustained emphasis on investment in product design, production efficiency, mutually profitable relationships with suppliers, and team engagement will help us drive value for our shareholders and future earnings potential for the Company.

 

Capital Funding

While we intend to become profitable and increasingly efficient over time, we also anticipate that our operating expenses will continue to remain consistently high as we maintain our current growth trajectory, scale the production of our megawatt charging stations and continue to invest in research and development of core proprietary products. We therefore anticipate a continued focus on capital financing and strategic partnership with other entities that mirror our commitment to electrification and provide infusions of working capital to fund development and operations. There is no guarantee that we will be able to realize the desired return on our investments.

Results of Operations

 

The following table sets forth certain statement of operations data for the three month periods ended March 31, 2024 and 2023 (dollars in thousands):

 

   Three Months Ended March 31, 
   2024   % of
Total
operating
expenses
   2023   % of
Total
operating
expenses
   Change 
                     
Revenue  $4    %  $    %  $4 
                          
Cost of revenue   3    -            3 
Depreciation   18                18 
Total cost of revenue   21    -            21 
Gross loss   (17)   -            (17)
                          
Operating expenses                         
Research and development   395    6    3,962    30    (3,567)
General and administrative   6,151    94    9,488    70    (3,337)
Advertising   22        34    0    (12)
                          
Total operating expenses   6,568    100    13,484    100    (6,916)
                          
Operating loss   (6,585)       (13,484)       6,899 
                          
Other income, net   44        1,314        (1,270)
                          
Net loss  $(6,541)   %  $(12,170)   %  $5,629 

 

 - 19 - 
 

 

Revenue

 

Three months ended March 31, 2024 vs. 2023. We recognized charging revenue during the first quarter of 2024 of approximately $4 thousand from the delivery of electricity to customer electric vehicles through our NxuOne™ megawatt charging station in Mesa, Arizona. Prior to September 2023, the Company had never generated revenue.

 

Cost of revenue

 

Three months ended March 31, 2024 vs. 2023. We recognized cost of revenue during the first quarter of 2024 of approximately $0.02 million. The cost of revenue represents energy costs and capitalized depreciation related to charging station services.

 

Gross loss

 

Three months ended March 31, 2024 vs. 2023. We recognized gross loss during the first quarter of 2024 of approximately $0.02 million. Gross loss represents revenue less energy costs and capitalized depreciation related to charging station services.

 

Research and development

 

Three months ended March 31, 2024 vs. 2023. Research and development decreased $3.5 million from $4.0 million during the first quarter of 2023 to $0.4 million in the first quarter of 2024 as we paused development and production of our battery technologies to focus on development of our megawatt charging stations and utilized labor hours from research and development team in construction of our megawatt charging units. We expect to continue to invest in research and development as we continue to bring our products and services to market.

 

General and administrative

 

Three months ended March 31, 2024 vs. 2023. General and administrative expenses decreased $3.3 million from $9.5 million during the first quarter of 2023 to $6.2 million in the first quarter of 2024. The reduction in general and administrative expense was primarily due to decreases in stock-based compensation and employee payroll and benefits, due to less vesting expense and a smaller team compared to the three months ended March 31, 2023. Additionally, we incurred less costs in connection with capital offerings in the first quarter of 2024 in comparison to the first quarter of 2023. 

  

Other income, net

 

Three months ended March 31, 2024 vs. 2023. Other income, net decreased by $1.3 million from the first quarter of 2023 to the first quarter of 2024 primarily as a result of a $2.3 million gain on the fair value of long-term debt and warrant liability in 2023 compared to a gain of $0.04 million in 2024, partially offset by $1.0 million of warrant expense in 2023. See Note 14 – Fair Value of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Quarterly Report on Form 10-Q for further discussion.

  

Liquidity and Capital Resources

 

As disclosed in Note 1 – Organization and Basis of Presentation of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Form 10-Q, the accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. 

 

During the three months ended March 31, 2024, the Company incurred a net loss of approximately $6.5 million and had net cash used in operating activities of $3.5 million. On March 31, 2024, the Company had $9.2 million in cash and an accumulated deficit of approximately $266.2 million.

 

During the three months ended March 31, 2024, the Company raised approximately $10.7 million, net of offering costs and commissions, through its ATM. As of March 31, 2024, the Company received the maximum amount of capital available under the shelf registration and is currently unable to continue to raise capital with the ATM.

 

Because our working capital requirements depend upon numerous factors, there can be no assurance that our current cash resources will be sufficient to fund our operations. Thus, we will require immediate additional financing to fund future operations. There can be no assurance, however, that we will be able to obtain funds on acceptable terms, if at all. The Company cannot provide any assurance that unforeseen circumstances that could occur at any time within the next twelve months or thereafter will not increase the need for the Company to raise additional capital on an immediate basis. The Company cannot provide any assurance that access to capital will be readily available when needed. 

 

 - 20 - 
 

 

These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year after the date these financial statements are issued. Company management is addressing this risk by pursuing all available options for funding, including accessing the public markets. The Company plans to continue considering all avenues available to it in order to obtain the necessary capital to be able to continue as a going concern and to execute on our business objectives including but not limited to through secondary offerings, debt financing, private placements, public offerings and equity lines of credit, and exploring other options, including other strategic alternatives for its business. The Company’s success is dependent upon achieving its strategic and financial objectives, including continuing to acquire capital through public markets as we work diligently to achieve future operational revenue goals. The Company cannot provide any assurance that access to capital will be readily available when needed or that it will be successful in implementing any additional strategic alternative, which may be subject to the satisfaction of conditions beyond the Company’s control.

 

The table below sets forth a summary of our cash flows for the three months ended March 31, 2024 and 2023 (in thousands):

 

   Three Months Ended
March 31,
 
   2024   2023 
         
Net cash used in operating activities  $(3,487)  $(9,370)
Net cash used in investing activities   (850)   (94)
Net cash provided by financing activities   10,672    19,662 

 

Net cash used in operating activities. Net cash used in operating activities during the three months ended March 31, 2024 was $3.5 million. The use of cash resulted primarily from a net loss of $6.5 million, partially offset by employee stock-based compensation expense of $2.7 million and net changes in working capital.

 

Net cash used in operating activities during the three months ended March 31, 2023, was $9.4 million. The use of cash resulted primarily from a net loss of $12.3 million, offset by employee and non-employee stock-based compensation expense of $5.9 million, net changes in working capital and changes in the fair value of convertible debt. 

 

Net cash used in investing activities. Net cash used in investing activities for the three months ended March 31, 2024 was $0.9 million. The cash used in investing activities was related to production of NxuOne™ charging station, and the purchase of other property and equipment, during the period.

 

Net cash used in investing activities for the three months ended March 31, 2023 was $0.1 million. Cash used in investing activities was related to purchases of property and equipment during the period.

 

Net cash provided by financing activities. Net cash provided by financing activities of $10.7 million during the three months ended March 31, 2024 primarily consisted of proceeds from stock issued under the ATM.

 

Net cash provided by financing activities of $19.7 million during the three months ended March 31, 2023, primarily consisted of proceeds from stock and convertible debt issuance offset by payments on convertible debt.

 

Off-balance sheet arrangements and contractual obligations

 

We did not have, during the periods presented, and we do not currently have, any off-balance sheet arrangements.

 

We have contractual lease obligations for our two properties with initial lease terms ending in the summer of 2025. The lease agreement for our warehouse facility in Mesa, Arizona includes one or more options to renew with renewal terms that can extend the lease term by five years or more. We added one equipment lease during the three months ended March 31, 2024, with a lease term ending in December 2025. In addition, we have obligations under our convertible debt facility to repay the remaining balance not converted into equity at the maturity date two years from issuance. See Note 12 - Convertible Notes and Warrant Liability of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Form 10-Q for further discussion.

 

Critical Accounting Estimates

 

There have been no material changes to the items disclosed as critical accounting policies and estimates under “Liquidity and Capital Resources—Critical Accounting Estimates” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of the 2023 Form 10-K.

 

 - 21 - 
 

 

Item 3.  Quantitative and Qualitative Disclosures about Market Risk

 

Not required.

 

Item 4.  Controls and Procedures

 

Our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively) have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Security Exchange Act of 1934, as amended, (the “Exchange Act”) as of March 31, 2024, the end of the period covered by this Form 10-Q (the “Evaluation Date”). They have concluded that, as of the Evaluation Date, these disclosure controls and procedures were effective to ensure that material information relating to the Company and its consolidated subsidiaries would be made known to them by others within those entities and would be disclosed on a timely basis. The Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are designed, and are effective, to give reasonable assurance that the information required to be disclosed by us in reports that we file under the Exchange Act is recorded, processed, summarized and reported within the time period specified in the rules and forms of the SEC. They have also concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports that are filed or submitted under the Exchange Act are accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. 

 

Changes in Internal Control over Financial Reporting

 

During the quarter ended March 31, 2024, there were no changes in our “internal control over financial reporting” (as defined in Rule 13a-15(f) and 15d-15(f)under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

See Note 10 – Commitments and Contingencies of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Form 10-Q.

 

Item 1A. Risk Factors

 

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in the section entitled “Risk Factors,” in the 2023 Form 10-K, which could materially affect our business, financial condition, or future results. As of the date of this Form 10-Q, there have been no material changes to the risk factors disclosed in the section entitled “Risk Factors” in our 2023 Form 10-K other than as set forth below: 

 

Our Class A common stock may be delisted from Nasdaq if we do not maintain compliance with Nasdaqs continued listing requirements. If our Class A common stock is delisted, it could negatively impact the Company. 

 

Continued listing of a security on Nasdaq is conditioned upon compliance with various continued listing standards. On April 2, 2024, we received a notice from Nasdaq stating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq (the “Bid Price Requirement”). 

 

No assurances can be provided that we will regain compliance with the minimum bid price requirement within the appeal period. If the Company’s Class A common stock ultimately were to be delisted for any reason, it could negatively impact the Company by (i) reducing the liquidity and market price of the Company’s Class A common stock; (ii) reducing the number of investors willing to hold or acquire the Company’s Class A common stock, which could negatively impact the Company’s ability to raise equity financing; (iii) limiting the Company’s ability to use a registration statement to offer and sell freely tradable securities, thereby preventing the Company from accessing the public capital markets; and (iv) impairing the Company’s ability to provide equity incentives to its employees. 

 

We have incurred significant losses since our inception, and we expect to continue to incur losses for the foreseeable future. Accordingly, our financial condition raises substantial doubt regarding our ability to continue as a going concern.

 

During the three-month period ended March 31, 2024, we incurred a net loss of $6.6 million and had net cash used in operating activities of $3.4 million. As of March 31, 2024, we had $9.2 million in cash and an accumulated deficit of $266.3 million. The Company cannot provide any assurance that unforeseen circumstances that could occur at any time within the next twelve months or thereafter will not increase the need for the Company to raise additional capital on an immediate basis. Additionally, the Company cannot provide any assurance that access to capital will be readily available when needed. These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year after the date these financial statements are issued. The report of our independent registered public accountant on our financial statements as of and for the years ended December 31, 2023 and 2022 also includes explanatory language describing the existence of substantial doubt about our ability to continue as a going concern. See Note 1 – Organization and Basis of Presentation of our accompanying unaudited condensed consolidated financial statements included in Part I, Item 1, Financial Statements of this Form 10-Q and “—Liquidity and Capital Resources” in Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations of this Form 10-Q for further information.

 

 - 22 - 
 

 

If we are unable to satisfy our capital requirements, we could be required to adopt one or more of the following alternatives: delaying the implementation of or revising certain aspects of our business strategy; reducing or delaying the development of our products; reducing or delaying capital spending, product development spending and marketing and promotional spending; entering into financing agreements on unattractive terms; and/or significantly curtailing or discontinuing operations.

 

There can be no assurance that we would be able to take any of the actions referred to above because of a variety of commercial or market factors, including, without limitation, market conditions being unfavorable for an equity or debt issuance or similar transactions. In addition, such actions, if taken, may not enable us to satisfy our capital requirements if the actions that we are able to consummate do not generate a sufficient amount of additional capital. If we are ultimately unable to satisfy our capital requirements, we would likely need to dissolve and liquidate our assets under the bankruptcy laws or otherwise.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 

 

 None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

Rule 10b5-1 Trading Plans

 

During the three months ended March 31, 2024, no director or officer of the Company adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as such terms are defined under Item 408(a) of Regulation S-K).

 

Item 6. Exhibits  

 

Exhibit No.  Exhibit Description 
3.1 Certificate of Incorporation of Nxu, Inc. (incorporated by reference to Exhibit 3.1 of the Company’s Form 10-K filed with the SEC on April 1, 2024)
   
3.2 Certificate of Amendment to the Certificate of Incorporation of Nxu, Inc., dated December 26, 2023 (incorporated by reference to Exhibit 3.2 of the Company’s Form 8-K filed with the SEC on December 27, 2023)
   
3.3 Certificate of Designations of Series A Convertible Preferred Stock of Nxu, Inc., dated December 22, 2023 (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed with the SEC on December 27, 2023)
   
3.4 Bylaws of Nxu, Inc. (incorporated by reference to Exhibit 3.4 of the Company’s Form 10-K filed with the SEC on April 1, 2024)
   
10.1+ Letter Agreement dated April 5, 2024 by and between the Company and Britt Ide (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed with the SEC on April 5, 2024)
   
10.2+ Letter Agreement dated April 5, 2024 by and between the Company and Caryn Nightengale Ide (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed with the SEC on April 5, 2024)
   
10.3+ Letter Agreement dated April 5, 2024 by and between the Company and Jessica Billingsley (incorporated by reference to Exhibit 10.3 of the Company’s Form 8-K filed with the SEC on April 5, 2024)
   
31.1  Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d - 14(a)

 

 - 23 - 
 

 

31.2  Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d - 14(a)
     
32.1*  Certification of Chief Executive Officer and Chief Financial Officer under Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS  Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. 
     
101.SCH  Inline XBRL Taxonomy Extension Schema Document 
     
101.CAL  Inline XBRL Taxonomy Extension Calculation Linkbase Document 
     
101.DEF  Inline XBRL Taxonomy Extension Definition Linkbase Document 
     
101.LAB  Inline XBRL Taxonomy Extension Label Linkbase Document 
     
101.PRE  Inline XBRL Taxonomy Extension Presentation Linkbase Document 
     
104  Cover Page Interactive Data File (embedded within the Inline XBRL document) 

 

*Furnished herewith. This exhibit should not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

+Management contract or compensatory plan or arrangement.

 

 - 24 - 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  Nxu, Inc.
     
     
Date: May 10, 2024 By:    /s/ Sarah Wyant
    Sarah Wyant
    Chief Financial Officer
    (Principal Financial Officer)

 

 

- 25 -

 

 

 

 

 

Exhibit 31.1

 

Certification of Principal Executive Officer Required by

Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended,

as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

I, Mark Hanchett, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Nxu, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 Date: May 10, 2024 By: /s/ Mark Hanchett  
  Mark Hanchett  
  Chief Executive Officer  

 

 

 

 

 

 

 

Exhibit 31.2

 

Certification of Principal Financial Officer Required by

Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended,

as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

I, Sarah Wyant, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Nxu, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

Date: May 10, 2024 By: /s/ Sarah Wyant  
  Sarah Wyant  
  Interim Chief Financial Officer  

 

 

 

 

 

 

 

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Nxu, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2024 (the “Report”), the undersigned hereby certify in their capacities as Chief Executive Officer and Chief Financial Officer of the Company, respectively, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

 

Date: May 10, 2024 By: /s/ Mark Hanchett  
  Mark Hanchett  
  Chief Executive Officer  
     

 

 

Date: May 10, 2024 By: /s/ Sarah Wyant  
  Sarah Wyant  
  Interim Chief Financial Officer  
     

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 

 

 

v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 10, 2024
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 1-41509  
Entity Registrant Name Nxu, Inc.  
Entity Central Index Key 0001722969  
Entity Tax Identification Number 92-2819012  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 1828 N. Higley Rd. Ste 116  
Entity Address, City or Town Mesa  
Entity Address, State or Province AZ  
Entity Address, Postal Zip Code 85205  
City Area Code (760)  
Local Phone Number 515-1133  
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share  
Trading Symbol NXU  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period true  
Entity Shell Company false  
Common Class A [Member]    
Entity Common Stock, Shares Outstanding   11,930,986
Common Class B [Member]    
Entity Common Stock, Shares Outstanding   258,503
v3.24.1.1.u2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash $ 9,181 $ 2,846
Prepaid expenses and other current assets 976 999
Notes receivable from related party 250 250
Total current assets 10,407 4,095
Property and equipment, net 4,447 3,865
Right-of-use assets 2,951 1,507
Investment in Lynx 3,000 3,000
Intangible assets, net 30 20
Other assets 729 772
Total assets 21,564 13,259
Current Liabilities:    
Accounts payable and accrued liabilities 3,498 3,371
Variable share settled restricted stock units 1,738 1,334
Current portion of operating lease liability 1,720 864
Other current liabilities 40
Total current liabilities 6,956 5,609
Lease liability, net of current portion 1,300 688
Convertible debt and warrant liability, at fair value 21 65
Other long-term liabilities 133 233
Total liabilities 8,410 6,595
Stockholders' Equity (Deficit):    
Additional paid-in capital 279,332 266,302
Accumulated deficit (266,179) (259,638)
Total stockholders' equity 13,154 6,664
Total liabilities and stockholders' equity 21,564 13,259
Common Class A [Member]    
Stockholders' Equity (Deficit):    
Common stock par value 1
Common Class B [Member]    
Stockholders' Equity (Deficit):    
Common stock par value
Series A Preferred Stock [Member]    
Stockholders' Equity (Deficit):    
Preferred stock par value
v3.24.1.1.u2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Common Class A [Member]    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 4,000,000,000 4,000,000,000
Common stock, shares issued 11,930,986 2,563,288
Common stock, shares outstanding 11,930,986 2,563,288
Common Class B [Member]    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 1,000,000,000 1,000,000,000
Common stock, shares issued 252,503 243,503
Common stock, shares outstanding 252,503 243,503
Series A Preferred Stock [Member]    
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 5,000 5,000
Preferred stock, shares issued 0 1,000
Preferred stock, shares outstanding 0 1,000
v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 4
Cost of revenue 3
Depreciation 18
Total cost of revenue 21
Gross loss (17)
Operating expenses:    
Research and development 395 3,962
General and administrative 6,151 9,488
Advertising 22 34
Total operating expenses 6,568 13,484
Operating loss (6,585) (13,484)
Other income (expense):